Skip to main content
Premium Trial:

Request an Annual Quote

BioDiscovery Licenses GeneSight Software to Syngenta Genomics Research Subsidiary

Premium

BioDiscovery has licensed its GeneSight microarray gene expression analysis software to the Torrey Mesa Research Institute, the genomics research arm of agrochemical giant Syngenta.

The software allows researchers to import microarray data into a database, and then analyze it using statistical techniques as well as visualization tools.

“We need a comprehensive statistical analysis tool that is easy to use and platform independent for our large-scale data analysis projects,” stated Tong Zhu, the scientist who leads the Institute’s microarray group. “We are pleased that GeneSight provides such a solution to our need.”

In addition to GeneSight, BioDiscovery of Marina Del Rey, Calif., also sells ImaGene, a microarray image processing and analysis tool, and CloneTracker, a data management program for microarray fabrication and production. The company signed a co-marketing agreement with Corning in June to market its software with Corning’s gene arrays.

BioDiscovery did not disclose the financial terms for the license.

— MMJ

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.